REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kintor Pharmaceutical Limited (Hong Kong) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kintor Pharmaceutical Limited Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Kintor Pharmaceutical Limited is focused on the R&D and commercialization of innovative drugs and therapies. The company has products cover the field of prostate cancer, breast cancer, liver cancer, hair loss, etc. The company was established in 2018, headquartered in Suzhou City, China._x000D_

Headquarters
Unit 401, Block C4, Bio-Nano Park, No. 218 Xing Hu Street, Suzhou Industrial Park
Suzhou; Jiangsu;

Contact Details: Purchase the Kintor Pharmaceutical Limited (Hong Kong) report to view the information.

Website: http://www.kintor.com.cn

Basic Information
Total Employees:
Purchase the Kintor Pharmaceutical Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Kintor Pharmaceutical Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the Kintor Pharmaceutical Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Kintor Pharmaceutical Limited (Hong Kong) report to view the information.
Incorporation Date:
May 16, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
9.16%
Purchase this report to view the information.
5.56%
Purchase this report to view the information.
Subsidiaries
Kintor Pharmaceutical Ireland (Ireland)
100%
Kintor Pharmaceuticals Inc. (United States)
100%
Kintor Science Limited
100%
Company Performance
Financial values in the chart are available after Kintor Pharmaceutical Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
-66.9%▼
Operating profit (EBIT)
67.11%▲
EBITDA
69.78%▲
Net Profit (Loss) for the Period
66.29%▲
Total assets
-60.54%▼
Total equity
-70.46%▼
Return on Equity (ROE)
-2.26%▼
Debt to Equity Ratio
36.64%▲
Quick Ratio
-1.13%▼
Cash Ratio
-1.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo